Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis.
Radiother Oncol
; 127(2): 292-298, 2018 May.
Article
in En
| MEDLINE
| ID: mdl-29606522
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Antineoplastic Agents, Alkylating
/
Dacarbazine
/
Glioma
Type of study:
Diagnostic_studies
/
Guideline
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
Radiother Oncol
Year:
2018
Document type:
Article
Country of publication:
Irlanda